{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Foncologypodcast.simplecast.com%2Fepisodes%2Fmbc-care-lWQSrK4f","width":444,"version":"1.0","type":"rich","title":"Advancing the Care of Patients With HR-Positive/HER2-Negative Metastatic Breast Cancer","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/b918171a-e3a4-454a-b1d5-a2f929e951f3/100399-breast-high-risk-2-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/d27a739f-d076-4ff9-8d33-ea050e993301\" height=\"200\" width=\"100%\" title=\"Advancing the Care of Patients With HR-Positive/HER2-Negative Metastatic Breast Cancer\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Listen to Manali Bhave, MD, and Erin F. Cobain, MD, discuss their management of patients with HR-positive/HER2-negative metastatic breast cancer including the current treatment algorithm, implementing genomic testing for assessing molecular resistance and guiding treatment decisions, and answering healthcare professional questions on how to personalize therapy for these patients."}